{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:05:14Z","timestamp":1790791514686,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jconrel.2024.05.033","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T14:20:19Z","timestamp":1717597219000},"page":"351-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Targeted Photodynamic Therapy using a Vectorized Photosensitizer coupled to Folic Acid Analog induces Ovarian Tumor Cell Death and inhibits IL-6-mediated Inflammation"],"prefix":"10.1016","volume":"371","author":[{"given":"L\u00e9a","family":"Boidin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Moinard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Moussaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux","family":"Merlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Moral\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume Paul","family":"Grolez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Baydoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirah","family":"Mohd-Gazzali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hafizie Dianel Mohd","family":"Tazizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan Hadi Abd","family":"Allah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohan","family":"Kerbage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Arnoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Acherar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Frochot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadira","family":"Delhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.05.033_bb0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.21037\/cco-20-34","article-title":"Epidemiology of ovarian Cancer","volume":"9","author":"Gaona-Luviano","year":"2020","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13048-019-0579-0","article-title":"Maintenance therapy for recurrent epithelial ovarian Cancer: current therapies and future perspectives \u2013 a review","volume":"12","author":"Gupta","year":"2019","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian Cancer: a review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0020","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.21037\/gs-20-544","article-title":"Role of biomarkers for early detection of ovarian Cancer recurrence","volume":"9","author":"Giampaolino","year":"2020","journal-title":"Gland Surg."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian Cancer (CHORUS): an open-label, randomised, controlled, Non-Inferiority Trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/AOG.0000000000004173","article-title":"Updates and new options in advanced epithelial ovarian Cancer treatment","volume":"137","author":"Kurnit","year":"2021","journal-title":"Obstet. Gynecol."},{"issue":"Suppl. 24","key":"10.1016\/j.jconrel.2024.05.033_bb0035","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1002\/cncr.32500","article-title":"Treatment of recurrent epithelial ovarian Cancer","volume":"125","author":"Pignata","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0040","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.3390\/jcm10010041","article-title":"Microscopic peritoneal residual disease after complete macroscopic Cytoreductive surgery for advanced high grade serous ovarian Cancer","volume":"10","author":"Aza\u00efs","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cyto.2012.01.015","article-title":"Inflammation and ovarian Cancer","volume":"58","author":"Macci\u00f2","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118080","article-title":"Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian Cancer","volume":"10","author":"Isobe","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12307-018-0215-3","article-title":"Ascites IL-10 promotes ovarian Cancer cell migration","volume":"11","author":"Lane","year":"2018","journal-title":"Cancer Microenviron."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0060","first-page":"1715","article-title":"Expression of IL-10 in patients with ovarian carcinoma","volume":"26","author":"Mustea","year":"2006","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0065","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/1097-0142(19940401)73:7<1882::AID-CNCR2820730718>3.0.CO;2-R","article-title":"Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian Cancer","volume":"73","author":"Plante","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0070","first-page":"375","article-title":"Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian Cancer and benign ovarian tumors","volume":"31","author":"Nowak","year":"2010","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0075","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.2174\/138161212802002797","article-title":"Interleukin-6\/Interleukin-6 receptor pathway as a new therapy target in epithelial ovarian Cancer","volume":"18","author":"Dijkgraaf","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0080","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-11-0945","article-title":"Interleukin-6 as a therapeutic target in human ovarian Cancer","volume":"17","author":"Coward","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0085","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.bmc.2005.02.025","article-title":"Design, synthesis, and biological evaluation of folic acid targeted Tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy","volume":"13","author":"Schneider","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2019.07.003","article-title":"Cell death in photodynamic therapy: from oxidative stress to anti-tumor immunity","volume":"1872","author":"Donohoe","year":"2019","journal-title":"Biochimica et Biophysica Acta (BBA) - reviews on Cancer"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0095","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/php.13253","article-title":"Photodynamic therapy and immunity: an update","volume":"96","author":"Falk-Mahapatra","year":"2020","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0100","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nm.2472","article-title":"Intraoperative tumor-specific fluorescence imaging in ovarian Cancer by folate receptor-? Targeting: first in-human results","volume":"17","author":"van Dam","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0105","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1200\/JCO.22.00291","article-title":"A phase III study of Pafolacianine injection (OTL38) for intraoperative imaging of folate receptor-positive ovarian Cancer (study 006)","volume":"41","author":"Tanyi","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0110","series-title":"Advances in Photodynamic Therapy: Basic, Translational, and Clinical","author":"Hamblin","year":"2008"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0115","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/archsurg.1991.01410270062011","article-title":"Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms","volume":"126","author":"Sindelar","year":"1991","journal-title":"Arch. Surg."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0120","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0360-3016(93)90066-5","article-title":"Phase I study of Debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors","volume":"25","author":"Delaney","year":"1993","journal-title":"International J Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0125","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1158\/1078-0432.CCR-05-1625","article-title":"A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal Carcinomatosis and Sarcomatosis","volume":"12","author":"Hahn","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0130","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3390\/ph15081034","article-title":"Residual microscopic peritoneal metastases after macroscopic complete Cytoreductive surgery for advanced high-grade serous ovarian carcinoma: a target for folate receptor targeted photodynamic therapy?","volume":"15","author":"Moinard","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bmc.2016.10.004","article-title":"Folic acid conjugates with photosensitizers for Cancer targeting in photodynamic therapy: synthesis and Photophysical properties","volume":"25","author":"Stallivieri","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9041185","article-title":"Photodynamic therapy using a new folate receptor-targeted photosensitizer on peritoneal ovarian Cancer cells induces the release of extracellular vesicles with Immunoactivating properties","volume":"9","author":"Baydoun","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0145","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.3390\/ijms241411288","article-title":"Folate receptor targeted photodynamic therapy: a novel way to stimulate anti-tumor immune response in intraperitoneal ovarian Cancer","volume":"24","author":"Baydoun","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0150","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejps.2016.08.045","article-title":"Stability of folic acid under several parameters","volume":"93","author":"Gazzali","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/ph14020138","article-title":"Photophysical properties of Protoporphyrin IX, Pyropheophorbide-a and Photofrin\u00ae in different conditions","volume":"14","author":"Myrzakhmetov","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0160","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.3390\/cancers13164109","article-title":"A warp-knitted light-emitting fabric-based device for in vitro photodynamic therapy: description, characterization, and application on human Cancer cell lines","volume":"13","author":"Th\u00e9cua","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0165","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.3390\/molecules26175304","article-title":"Conjugated \u03b2-Cyclodextrin enhances the affinity of folic acid towards FR\u03b1: molecular dynamics study","volume":"26","author":"Al-Thiabat","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0170","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1021\/acsabm.0c01227","article-title":"Design of a Targeting and Oxygen-Independent Platform to improve photodynamic therapy: a proof of concept","volume":"4","author":"Larue","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0175","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.2174\/0929867322666150729113912","article-title":"The interest of folic acid in targeted photodynamic therapy","volume":"22","author":"Stallivieri","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0180","doi-asserted-by":"crossref","first-page":"44","DOI":"10.21037\/cco-20-49","article-title":"Role of Hyperthermic intraperitoneal chemotherapy in ovarian Cancer","volume":"9","author":"Medina-Castro","year":"2020","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0185","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/IGC.0000000000000007","article-title":"Ovarian Cancer: sites of recurrence","volume":"23","author":"Amate","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0190","doi-asserted-by":"crossref","first-page":"1023177","DOI":"10.3389\/fonc.2022.1023177","article-title":"The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers","volume":"12","author":"Huang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0195","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.2147\/CMAR.S179189","article-title":"IL-6 and ovarian Cancer: inflammatory cytokines in promotion of metastasis","volume":"10","author":"Browning","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0200","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1572-1000(04)00037-7","article-title":"Interstitial photodynamic therapy for prostate Cancer: a developing modality","volume":"1","author":"Martin","year":"2004","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0205","doi-asserted-by":"crossref","unstructured":"Ogawa, K.; Kobuke, Y. Recent Advances in Two-Photon Photodynamic Therapy. Anti Cancer Agents Med. Chem. 8, 269\u2013279.","DOI":"10.2174\/187152008783961860"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0210","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/nano13040673","article-title":"X-ray activated Nanoplatforms for deep tissue photodynamic therapy","volume":"13","author":"Souris","year":"2023","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0215","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1042\/BJ20150942","article-title":"New photosensitizers for photodynamic therapy","volume":"473","author":"Abrahamse","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0220","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1142\/S1088424617300014","article-title":"Strategies for optimizing the delivery to tumors of macrocyclic photosensitizers used in photodynamic therapy (PDT)","volume":"21","author":"Moret","year":"2017","journal-title":"J. Porphyrins Phthalocyanines"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0225","series-title":"Recent Developments of Porphyrin Photosensitizers in Photodynamic Therapy","author":"A, A.; Ghosh, M","year":"2023"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0230","first-page":"11","article-title":"Folic acid and its role in Oral health: a narrative review","volume":"2023","author":"Albu","year":"1994","journal-title":"Processes"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0235","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ddr.21545","article-title":"Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems","volume":"80","author":"Narmani","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0240","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10555-008-9155-6","article-title":"Tumor detection using folate receptor-targeted imaging agents","volume":"27","author":"Sega","year":"2008","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2022.214702","article-title":"Folate-based radiotracers for nuclear imaging and radionuclide therapy","volume":"470","author":"Wagner","year":"2022","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0250","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/annonc\/mdv250","article-title":"Targeting the folate receptor: diagnostic and therapeutic approaches to personalize Cancer treatments","volume":"26","author":"Ledermann","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0255","doi-asserted-by":"crossref","first-page":"52553","DOI":"10.18632\/oncotarget.9651","article-title":"Targeting folate receptor alpha for Cancer treatment","volume":"7","author":"Cheung","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0260","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1021\/jm100509v","article-title":"Folate-targeted therapies for Cancer","volume":"53","author":"Xia","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.117490","article-title":"Tumor microenvironment-responsive PEGylated heparin-Pyropheophorbide-a Nanoconjugates for photodynamic therapy","volume":"255","author":"Wu","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0270","doi-asserted-by":"crossref","first-page":"1604053","DOI":"10.1002\/adfm.201604053","article-title":"Activatable photosensitizers: agents for selective photodynamic therapy","volume":"27","author":"Li","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0275","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1021\/acs.molpharmaceut.7b01064","article-title":"cRGD peptide-conjugated Pyropheophorbide-a photosensitizers for tumor targeting in photodynamic therapy","volume":"15","author":"Li","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0280","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1021\/bc0603337","article-title":"Synthesis and in vitro testing of a Pyropheophorbide-a-fullerene Hexakis adduct Immunoconjugate for photodynamic therapy","volume":"18","author":"Rancan","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0285","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.chemphys.2006.07.040","article-title":"Photoinduced Electron and Energy Transfer in a New Porphyrin\u2013Phthalocyanine Triad","volume":"328","author":"Ermilov","year":"2006","journal-title":"Chem. Phys."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0290","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1039\/c0pp00107d","article-title":"Correlation of Photophysical parameters with macrocycle distortion in porphyrins with graded degree of saddle distortion","volume":"9","author":"R\u00f6der","year":"2010","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0295","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1038\/sj.onc.1203839","article-title":"Downmodulation of Caveolin-1 expression in human ovarian carcinoma is directly related to \u03b1-folate receptor overexpression","volume":"19","author":"Bagnoli","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047201","article-title":"Paradoxical impact of two folate receptors, FR\u03b1 and RFC, in ovarian Cancer: effect on cell proliferation, Invasion and Clinical Outcome","volume":"7","author":"Siu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0305","doi-asserted-by":"crossref","first-page":"15180","DOI":"10.1073\/pnas.1308827110","article-title":"Structures of human folate receptors reveal biological trafficking states and diversity in folate and Antifolate recognition","volume":"110","author":"Wibowo","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0310","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature12327","article-title":"Structural basis for molecular recognition of folic acid by folate receptors","volume":"500","author":"Chen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0315","doi-asserted-by":"crossref","first-page":"6780","DOI":"10.1021\/acs.biochem.8b00607","article-title":"Internalization of methotrexate conjugates by folate receptor-\u03b1","volume":"57","author":"Nogueira","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0320","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1479-5876-12-4","article-title":"Ovarian Cancer cell invasiveness is associated with discordant Exosomal sequestration of Let-7 miRNA and miR-200","volume":"12","author":"Kobayashi","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0325","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1039\/c0pp00345j","article-title":"The immunosuppressive side of PDT","volume":"10","author":"Mroz","year":"2011","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0330","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/eci.10.81","article-title":"Stimulation of anti-tumor immunity by photodynamic therapy","volume":"7","author":"Mroz","year":"2011","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2021.102392","article-title":"The induction of immunogenic cell death by photodynamic therapy in B16F10 cells in vitro is effected by the concentration of the photosensitizer","volume":"35","author":"Morais","year":"2021","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0340","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1871520620666200318101037","article-title":"Factors affecting photodynamic therapy and anti-tumor immune response","volume":"21","author":"Hamblin","year":"2021","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0345","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3892\/ijo.2022.5340","article-title":"Combined inhibition of IL-6 and IL-8 pathways suppresses ovarian Cancer cell viability and migration and tumor growth","volume":"60","author":"Zhang","year":"2022","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0350","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygyno.2015.05.009","article-title":"Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-\u03b1 and Interleukin-6 in predicting reduced progression-free survival in epithelial ovarian Cancer","volume":"138","author":"Kolomeyevskaya","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jconrel.2024.05.033_bb0355","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gore.2017.09.009","article-title":"Prolonged survival after intraperitoneal Interleukin-2 immunotherapy for recurrent ovarian Cancer","volume":"22","author":"Minor","year":"2017","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.jconrel.2024.05.033_bb0360","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12094-021-02668-9","article-title":"IFN-\u03b3 inhibits ovarian Cancer progression via SOCS1\/JAK\/STAT signaling pathway","volume":"24","author":"Gao","year":"2022","journal-title":"Clin. Transl. Oncol."},{"issue":"18","key":"10.1016\/j.jconrel.2024.05.033_bib361","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-11-0945","article-title":"Interleukin-6 as a therapeutic target in human ovarian cancer","volume":"17","author":"Coward","year":"2011","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592400316X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592400316X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T06:08:53Z","timestamp":1719295733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592400316X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":73,"alternative-id":["S016836592400316X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.05.033","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted Photodynamic Therapy using a Vectorized Photosensitizer coupled to Folic Acid Analog induces Ovarian Tumor Cell Death and inhibits IL-6-mediated Inflammation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.05.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}